Long Shot: Revance’s RT002 May Banish Frown Lines for 7 Months
Revance's investigational injectable—RT002—achieves median duration of 7 months, a phase 2 active comparator study now underway.
Revance's investigational injectable—RT002—achieves median duration of 7 months, a phase 2 active comparator study now underway.
Plastic surgery patients experiencing problematic volume loss in their face due to aging may be able to regain a more youthful appearance with the assistance of a fat transfer, according to Michelle Hardaway, MD, FACS, a board-certified plastic and reconstructive surgeon at the Aesthetic Plastic Surgery and Laser Center in Farmington, Mich.